BioNexus Gene Lab Corp: Form 8-K, filed Oct 10, 2024
Filed with the SEC on Oct 10, 2024 and accepted by EDGAR at Oct 10, 2024, 21:29 ET.
Items reported
- Item 5.07 Shareholder vote results
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001477932-24-006352. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.